International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||Survey to Assess International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center|
- prevalence of international travel [ Time Frame: 2 years ] [ Designated as safety issue: No ]of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT
- international travel was during a high-risk specific period [ Time Frame: 2 years ] [ Designated as safety issue: No ]Proportion of patients traveling to destinations that are at high risk areas for infections
- patients that sought pre-travel health advice [ Time Frame: 2 years ] [ Designated as safety issue: No ]among those who traveled to high risk areas for infections
- travelers that becomes ill and required medical attention [ Time Frame: 2 years ] [ Designated as safety issue: No ]during or after return from international travel.
|Study Start Date:||December 2011|
|Study Completion Date:||July 2013|
|Primary Completion Date:||July 2013 (Final data collection date for primary outcome measure)|
patients who received HSCT at MSKCC between 2005-2010
A self-administered patient questionnaire will be used to collect data that will assess the prevalence of international travel after HSCT and travel related morbidity and exposure risks among HSCT recipients.
The intervention is a self-administered questionnaire that is voluntarily completed by the subject. This questionnaire has been previously validated and demonstrated to be reproducible in English speaking travelers. The final version of the survey questionnaire consists of 49 questions.Patients who never traveled after HSCT will answer only eighteen questions related to their medical and HSCT history in addition to their demographics.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01504152
|United States, New York|
|Memorial Sloan-Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||Monika Shah, MD||Memorial Sloan-Kettering Cancer Center|